Decoding the Cognitive Trajectory of Hong Kong SuperAgers: a Longitudinal Follow-up Study (NCT05728801) | Clinical Trial Compass
UnknownNot Applicable
Decoding the Cognitive Trajectory of Hong Kong SuperAgers: a Longitudinal Follow-up Study
Hong Kong400 participantsStarted 2022-06-01
Plain-language summary
This is a prospective follow-up study conducted at the Department of Psychiatry, The Chinese University of Hong Kong. The participants, including high-performing elderly (SuperAgers), normal ageing elderly and neurocognitive disorder (NCD) patients will be re-invited from our previous cohort (2013-2014) (N=488).
Who can participate
Age range60 Years – 95 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* SuperAgers are determined by the scores of global cognitive function. This ensured that the participants are divided by a measure relevant to the current study without directly biasing the results toward the domain of interest;
* Normal aging: the cases with the scores of cognitive performance within 1.5 standard deviation (SD) of age and education matched normative values derived from our cohort study, of which presented with HK MoCA score greater than 26 and CDR score equal to 0;
* NCD patients are defined as: evidence of modest decline in one or more cognitive domains, which is set as ≥ 1.5 SD below the age- and education-adjusted normative scores; no interference with independence in everyday activities; and no comorbid major psychiatric disorders.
Exclusion Criteria:
* History of bipolar disorders or psychosis;
* History of major neurological deficits including stroke, transient ischemic attack or traumatic brain injury;
* Comorbidities with depressive symptoms.
What they're measuring
1
Global cognition will be measured by the Montreal Cognitive Assessment Hong Kong version (HK MoCA)
Timeframe: 2022-2024
2
Complex attention will be measured by Attention Network Test (ANT)